Your browser doesn't support javascript.
loading
Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.
Rajeshkumar, N V; Dutta, Prasanta; Yabuuchi, Shinichi; de Wilde, Roeland F; Martinez, Gary V; Le, Anne; Kamphorst, Jurre J; Rabinowitz, Joshua D; Jain, Sanjay K; Hidalgo, Manuel; Dang, Chi V; Gillies, Robert J; Maitra, Anirban.
Afiliación
  • Rajeshkumar NV; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Dutta P; Department of Cancer Imaging and Metabolism, Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Yabuuchi S; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • de Wilde RF; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Martinez GV; Department of Cancer Imaging and Metabolism, Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Le A; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Kamphorst JJ; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey.
  • Rabinowitz JD; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey.
  • Jain SK; Center for Infection and Inflammation Imaging Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Hidalgo M; Spanish National Cancer Research Center (CNIO), Melchor Fernandez Almagro 3, Madrid, Spain.
  • Dang CV; Abramson Cancer Center, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania. AMaitra@mdanderson.org dangvchi@exchange.upenn.edu.
  • Gillies RJ; Department of Cancer Imaging and Metabolism, Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Maitra A; Department of Pathology and Translational Molecular Pathology, Sheikh Ahmad Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. AMaitra@mdanderson.org dangvchi@exchange.upenn.edu.
Cancer Res ; 75(16): 3355-64, 2015 Aug 15.
Article en En | MEDLINE | ID: mdl-26113084

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteína p53 Supresora de Tumor / Ensayos Antitumor por Modelo de Xenoinjerto / Glucólisis / Naftalenos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Res Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteína p53 Supresora de Tumor / Ensayos Antitumor por Modelo de Xenoinjerto / Glucólisis / Naftalenos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Res Año: 2015 Tipo del documento: Article